Daniel Gaylin
CEO, NORC at the University of Chicago

President and Chief Executive Officer
M.P.A., Health Policy and Quantitative Analysis, Woodrow Wilson School of Public and International Affairs, Princeton University
B.A., Biological Basis of Behavior, University of Pennsylvania

Link to NORC website, including Dan Gaylin's publications.

Dan Gaylin is the President and Chief Executive Officer of NORC at the University of Chicago and works collaboratively with NORC's Board of Trustees and senior leaders to guide and execute all aspects of the organization's strategic vision, daily operations, research agenda, and client offerings. Previously, Gaylin held the role of Executive Vice President of Research Programs and oversaw all of NORC’s research departments, guiding implementation, development, partnerships and collaborations, and strategic planning.

Gaylin has more than 25 years of experience spanning government, think tanks and private research organizations. A nationally recognized expert in program evaluation, he has led multi-disciplinary teams in conducting health services research, policy formulation and policy analysis. Throughout his career, he has conducted numerous long-term, multi-million dollar projects that combine primary data collection and analysis, analysis of existing data, and qualitative research methods to gather and distill complex information of interest to policy makers, practitioners and the general public into recommendations for improving policy, programs, and practice. He has conducted research funded by a very wide range of Federal agencies and also has directed studies funded by major U.S. foundations and private organizations. He has numerous publications in leading peer-reviewed journals including the New England Journal of Medicine, JAMA, and Health Affairs.

Prior to NORC, Dan Gaylin served as Senior Advisor for Research and Planning at the U.S. Department of Health and Human Services (HHS). In this role, he managed development and implementation of annual research plans, providing leadership on defining and prioritizing research topics and resources, selecting appropriate research methods, overseeing development of RFPs, negotiating awards, and directing project officers managing task orders. He also headed initiatives to coordinate data strategy and research activities across HHS to develop coherent mechanisms for identifying research priorities and avoiding redundancy. He co-chaired the Prescription Drug Task Force that reported directly to the Secretary of HHS and the White House, and was technical lead in designing the Congressionally mandated evaluation of the Children’s Health Insurance Program. Prior to his work at HHS, he was a Vice President at the Lewin Group consultancy and a Research Associate and Program Manager at the Urban Institute.